Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Rahman MM, Sarker MAK, Hossain MM, Alam MS, Islam MM, Shirin L, et al. Association of p53 gene mutation with helicobacter pylori infection in gastric cancer patients and its correlation with clinicopathological and environmental factors. World J Oncol. 2019;10:46–544.
2. Yoshida T, Yamaguchi T, Maekawa S, Takano S, Kuno T, Tanaka K, et al. Identification of early genetic changes in well-differentiated intramucosal gastric carcinoma by target deep sequencing. Gastric Cancer. 2019;22:742–50.
3. Würl P, Weigmann F, Meye A, Fittkau M, Rose U, Berger D, et al. Detection of p53 autoantibodies in sera of gastric cancer patients and their prognostic relevance. Scand J Gastroenterol. 1997;32:1147–51.
4. Shiota G, Ishida M, Noguchi N, Takano Y, Oyama K, Okubo M, et al. Clinical significance of serum p53 antibody in patients with gastric cancer. Res Commun Mol Pathol Pharmacol. 1998;99:41–51.
5. Maehara Y, Kakeji Y, Watanabe A, Baba H, Kusumoto H, Kohnoe S, et al. Clinical implications of serum anti-p53 antibodies for patients with gastric carcinoma. Cancer. 1999;85:302–8.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献